Centralised authorisation procedure 2013

Updated 27 February 2014

The Danish share of assignments in the European pharmaceutical collaboration

The Danish Medicines Agency should have the greatest possible influence on decisions regarding new medicinal products and thereby the greatest possible influence on the future development of the European market for medicinal products.

Status for 2013 up to and including 4th quarter

Denmark was assigned 4 human rapporteur/co-rapporteur cases and 5 veterinary rapporteur/co-rapporteur case, which is respectively 2 % and 7 % of all assigned central procedure cases in 2013.

Figure 1: Amount of assigned (co)rapporteurships in the EU in 2013 up to and including 4th quarter

Figure 1: Amount of assigned (co)rapporteurships in the EU in 2013 up to and including 4th quarter 

Figure 2. Share of human Rap/Co-rap cases in 2013 up to and including 4th quarter

Figure 2. Share of human Rap/Co-rap cases 

Figure 3. Share of veterinary Rap/Co-rap cases in 2013 up to and including 4th quarter

Figure 3. Share of veterinary Rap/Co-rap cases